Inventor
MARLOW ALLISON L
US27 patents
⚠️ This page may combine multiple inventors who share the name “MARLOW ALLISON L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARRAY BIOPHARMA INC
15 patentsUS7732616B2Jun 8, 2010
Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof
ARRAY BIOPHARMA INC35 citations96
US7517994B2Apr 14, 2009
Heterocyclic inhibitors of MEK and methods of use thereof
ARRAY BIOPHARMA INC36 citations96
US7425637B2Sep 16, 2008
N3 alkylated benzimidazole derivatives as MEK inhibitors
ARRAY BIOPHARMA INC27 citations96
US7235537B2Jun 26, 2007
N3 alkylated benzimidazole derivatives as MEK inhibitors
ARRAY BIOPHARMA INC53 citations96
US7777050B2Aug 17, 2010
N3 alkylated benzimidazole derivatives as MEK inhibitors
ARRAY BIOPHARMA INC13 citations92
US7598383B2Oct 6, 2009
Heterocyclic inhibitors of MEK and methods of use thereof
ARRAY BIOPHARMA INC19 citations92
US7893065B2Feb 22, 2011
Heterocyclic inhibitors of MEK and methods of use thereof
ARRAY BIOPHARMA INC14 citations84
US7576072B2Aug 18, 2009
Heterocyclic inhibitors of MEK and methods of use thereof
ARRAY BIOPHARMA INC9 citations84
US7538120B2May 26, 2009
Method of treating inflammatory diseases
ARRAY BIOPHARMA INC11 citations84
US8003662B2Aug 23, 2011
Heterobicyclic thiophene compounds and methods of use
ARRAY BIOPHARMA INC9 citations82
US7723330B2May 25, 2010
Heterobicyclic pyrazole compounds and methods of use
ARRAY BIOPHARMA INC11 citations82
US8003805B2Aug 23, 2011
N3 alkylated benzimidazole derivatives as MEK inhibitors
ARRAY BIOPHARMA INC5 citations74
US7973170B2Jul 5, 2011
N3 alkylated benzimidazole derivatives as MEK inhibitors
ARRAY BIOPHARMA INC5 citations74
US7576114B2Aug 18, 2009
N3 alkylated benzimidazole derivatives as MEK inhibitors
ARRAY BIOPHARMA INC5 citations74
US7842816B2Nov 30, 2010
N3 alkylated benzimidazole derivatives as MEK inhibitors
ARRAY BIOPHARMA INC3 citations63
WALLACE ELI M
5 patentsUS8513293B2Aug 20, 2013
Methods of treating a hyperproliferative disorder or inhibiting cell growth in a mammal
WALLACE ELI M5 citations83
US8193231B2Jun 5, 2012
Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
WALLACE ELI M2 citations73
US8193230B2Jun 5, 2012
Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
WALLACE ELI M2 citations73
US8178693B2May 15, 2012
N3 alkylated benzimidazole derivatives as MEK inhibitors
WALLACE ELI M4 citations73
US8193229B2Jun 5, 2012
Method of treatment using N3 alkylated benzimidazole derivatives as MEK inhibitors
WALLACE ELI M2 citations62
MARLOW ALLISON L
4 patentsUS8101639B2Jan 24, 2012
6-oxo-1,6-dihydropyridine compounds as inhibitors of MEK and methods of use thereof
MARLOW ALLISON L4 citations61
US8101611B2Jan 24, 2012
Substituted pyridazines inhibitors of MEK
MARLOW ALLISON L4 citations61
US8211920B2Jul 3, 2012
6-oxo-1,6-dihydropyridine derivatives as inhibitors of MEK and methods of use thereof
MARLOW ALLISON L1 citations51
US8299076B2Oct 30, 2012
Crystalline forms of 2-(2-flouro-4-iodophenylamino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide
MARLOW ALLISON L0 citations47